Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder

Phase 2 Withdrawn Ewha Womans University

Non-randomizedParallel-groupOpen-labelTreatment

Summary

In this study, patients with major depressive disorder (MDD) who have insomnia symptom are treated with Seroquel XR in an open-label manner for a 4-week period with repeated measurements of insomnia symptoms and sleep parameters using polysomnography.

Timeline

Start: 2012-03
Primary completion: 2014-02
Completion: 2014-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Quetiapine	Small molecule	50 mg	—
Subject	Quetiapine	Small molecule	150 mg	—

Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder

Summary

Timeline

Drugs

Indications